Journal
IMMUNOGENETICS
Volume 70, Issue 10, Pages 625-632Publisher
SPRINGER
DOI: 10.1007/s00251-018-1073-3
Keywords
Comparative MHC; Nomenclature; IPD-MHC
Categories
Funding
- Scottish Government's strategic research program
- European Union [731014]
- BBSRC [BBS/E/I/00001710, BBS/E/I/00007030, BBS/E/I/00007038, BBS/E/I/00007039]
- BBSRC [BB/M011488/1] Funding Source: UKRI
Ask authors/readers for more resources
Significant progress has been made over the last decade in defining major histocompatibility complex (MHC) diversity at the nucleotide, allele, haplotype, diplotype, and population levels in many non-human species. Much of this progress has been driven by the increased availability and reduced costs associated with nucleotide sequencing technologies. This report provides an update on the activities of the comparative MHC nomenclature committee which is a standing committee of both the International Society for Animal Genetics (ISAG) and the International Union of Immunological Societies (IUIS) where it operates under the umbrella of the Veterinary Immunology Committee (VIC). A previous report from this committee in 2006 defined the role of the committee in providing guidance in the development of a standardized nomenclature for genes and alleles at MHC loci in non-human species. It described the establishment of the Immuno Polymorphism Database, IPD-MHC, which continues to provide public access to high quality MHC sequence data across a range of species. In this report, guidelines for the continued development of a universal MHC nomenclature framework are described, summarizing the continued development of each species section within the IPD-MHC project.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available